Publication: Association of FEF<inf>25%–75%</inf> and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma
dc.contributor.author | Watcharoot Kanchongkittiphon | en_US |
dc.contributor.author | Jonathan M. Gaffin | en_US |
dc.contributor.author | Lianne Kopel | en_US |
dc.contributor.author | Carter R. Petty | en_US |
dc.contributor.author | Mary E. Bollinger | en_US |
dc.contributor.author | Rachel L. Miller | en_US |
dc.contributor.author | Matthew Perzanowski | en_US |
dc.contributor.author | Elizabeth C. Matsui | en_US |
dc.contributor.author | Wanda Phipatanakul | en_US |
dc.contributor.other | Children's Hospital of Michigan | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Children's Hospital Boston | en_US |
dc.contributor.other | Harvard Medical School | en_US |
dc.contributor.other | Centre universitaire de santé McGill, Hôpital de Montreal Pour Enfants | en_US |
dc.contributor.other | University of Maryland School of Medicine | en_US |
dc.contributor.other | Columbia University Medical Center | en_US |
dc.contributor.other | The Johns Hopkins School of Medicine | en_US |
dc.date.accessioned | 2018-12-11T03:00:55Z | |
dc.date.accessioned | 2019-03-14T08:01:42Z | |
dc.date.available | 2018-12-11T03:00:55Z | |
dc.date.available | 2019-03-14T08:01:42Z | |
dc.date.issued | 2016-07-01 | en_US |
dc.identifier.citation | Annals of Allergy, Asthma and Immunology. Vol.117, No.1 (2016), 97-99 | en_US |
dc.identifier.doi | 10.1016/j.anai.2016.04.029 | en_US |
dc.identifier.issn | 15344436 | en_US |
dc.identifier.issn | 10811206 | en_US |
dc.identifier.other | 2-s2.0-84970002317 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/40795 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84970002317&origin=inward | en_US |
dc.subject | Immunology and Microbiology | en_US |
dc.title | Association of FEF<inf>25%–75%</inf> and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84970002317&origin=inward | en_US |